RIGL
Rigel Pharmaceuticals Inc
NASDAQ · Biotechnology
$34.15
+0.93 (+2.80%)
Open$33.46
Previous Close$33.22
Day High$35.00
Day Low$33.46
52W High$52.24
52W Low$15.50
Volume—
Avg Volume317.0K
Market Cap619.87M
P/E Ratio5.47
EPS$6.17
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+58.4% upside
Current
$34.15
$34.15
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 183.98M | 173.06M | 391.65M |
| Net Income | 17.94M | 15.19M | -57,293,222 |
| Profit Margin | 9.8% | 9.3% | -14.6% |
| EBITDA | 27.11M | 24.23M | -94,057,035 |
| Free Cash Flow | — | — | -78,875,103 |
| Rev Growth | +6.3% | +6.3% | +12.4% |
| Debt/Equity | 18.15 | 18.15 | 0.62 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |